For the past several years, pharmaceutical giant Pfizer has been under investigation by the U.S. Department of Justice for ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Large unusual trading volume in Pfizer, Inc. (PFE) put options that expire 30 days from now signals investors' bullish ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...